(R)-7-[N-Aminocarbonylmethyl-N-(2',4'-dichlorophenethyl)aminocarbonyl]-4-(2',4'-dichlorophenethyl)-1-(3',3'-diphenylpropyl)perhydro-1,4-diazepine-2,5-dione

ID: ALA2203816

PubChem CID: 71452201

Max Phase: Preclinical

Molecular Formula: C39H38Cl4N4O4

Molecular Weight: 768.57

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  NC(=O)CN(CCc1ccc(Cl)cc1Cl)C(=O)[C@H]1CC(=O)N(CCc2ccc(Cl)cc2Cl)CC(=O)N1CCC(c1ccccc1)c1ccccc1

Standard InChI:  InChI=1S/C39H38Cl4N4O4/c40-30-13-11-28(33(42)21-30)15-18-45-25-38(50)47(20-17-32(26-7-3-1-4-8-26)27-9-5-2-6-10-27)35(23-37(45)49)39(51)46(24-36(44)48)19-16-29-12-14-31(41)22-34(29)43/h1-14,21-22,32,35H,15-20,23-25H2,(H2,44,48)/t35-/m1/s1

Standard InChI Key:  YSUHYGYGQFSKDT-PGUFJCEWSA-N

Molfile:  

     RDKit          2D

 51 55  0  0  0  0  0  0  0  0999 V2000
    4.0874   -9.3613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0863  -10.1886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8011  -10.6015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5175  -10.1882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5147   -9.3576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7993   -8.9485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8009  -11.4265    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.3729   -8.9489    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.7968   -8.1235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5101   -7.7089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5076   -6.8839    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2208   -6.4692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7919   -6.4735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0787   -6.8881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3630   -6.4778    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0811   -7.7131    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9634   -6.8290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2184   -5.6443    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6084   -6.3197    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4144   -6.5047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9631   -7.6567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7743   -7.2456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6090   -8.1722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4139   -7.9865    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4263   -8.9767    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.9279   -5.8589    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.2676   -5.5684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7478   -4.8976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4070   -4.1461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8281   -3.4367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5821   -4.1358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6524   -3.4517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0733   -2.7431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6694   -2.0227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8402   -2.0154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4229   -2.7247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1816   -3.4136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3575   -3.4029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9352   -4.1127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3431   -4.8347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1659   -4.8419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8112   -8.7095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6360   -8.7270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0333   -9.4500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6022  -10.1523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9989  -10.8748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8246  -10.8927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2520  -10.1821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8529   -9.4625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2770   -8.7548    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   11.2228  -11.6152    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  3  7  1  0
  1  8  1  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 17 12  1  6
 12 18  2  0
 17 19  1  0
 19 20  1  0
 17 21  1  0
 20 22  1  0
 21 23  1  0
 22 24  1  0
 23 24  1  0
 23 25  2  0
 20 26  2  0
 19 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 29 31  1  0
 30 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 30  1  0
 31 37  2  0
 37 38  1  0
 38 39  2  0
 39 40  1  0
 40 41  2  0
 41 31  1  0
 24 42  1  0
 42 43  1  0
 43 44  1  0
 44 45  2  0
 45 46  1  0
 46 47  2  0
 47 48  1  0
 48 49  2  0
 49 44  1  0
 49 50  1  0
 47 51  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA2203816

   (5R)-N-(2-amino-2-oxoethyl)-N,1-bis[2-(2,4-dichlorophenyl)ethyl]-4-(3,3-diphenylpropyl)-3,7-dioxo-1,4-diazepane-5-carboxamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 768.57

Molecular Weight (Monoisotopic): 766.1647

AlogP: 7.05

#Rotatable Bonds: 14

Polar Surface Area: 104.02

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: 2

HBA (Lipinski): 8

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 2

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: 6.80

CX LogD: 6.80

Aromatic Rings: 4

Heavy Atoms: 51

QED Weighted: 0.15

Np Likeness Score: -0.80

References

1. Moure A, Orzáez M, Sancho M, Messeguer A..  (2012)  Synthesis of enantiomerically pure perhydro-1,4-diazepine-2,5-dione and 1,4-piperazine-2,5-dione derivatives exhibiting potent activity as apoptosis inhibitors.,  22  (23): [PMID:23079529] [10.1016/j.bmcl.2012.09.078]

Source

Source(1):

• Scientific Literature